← Back to Search

Home-based aerobic exercise for Cognitive Aging (PEACH Trial)

Phase < 1
Waitlist Available
Led By Kirk I Erickson, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights

PEACH Trial Summary

This trial is testing a 12-week home-based exercise intervention to see if it is feasible and acceptable for Black and African American adults. They also want to see if the intervention improves cognitive and psychological functioning.

Eligible Conditions
  • Cognitive Aging
  • Adverse Childhood Experiences

PEACH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to exercise intervention program: Number of sessions completed
Secondary outcome measures
Adherence to exercise intervention program: Average minutes spent in moderate to vigorous exercise
Other outcome measures
Adherence to exercise intervention program: Average duration of sessions
Mean change in Dimensional Card Sort performance
Mean change in Flanker performance
+11 more

PEACH Trial Design

1Treatment groups
Experimental Treatment
Group I: Home-based aerobic exerciseExperimental Treatment1 Intervention
Un-supervised exercise will be held 3 times a week for 60 minutes in the participant's home

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,342,337 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,535 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,017,059 Total Patients Enrolled
7 Trials studying Cognitive Aging
823 Patients Enrolled for Cognitive Aging

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor have an age requirement, and if so, is it higher than 25 years?

"The target population for this clinical trial are those aged between 30 and 55 years old."

Answered by AI

For whom is this clinical trial most suitable?

"For this research study, 40 participants with cognitive aging must be enrolled. Prospective candidates should meet the prerequisites: between 30 and 55 years old, experienced a traumatic event before age 10 according to self-reported evidence, Black or African American race, access to internet at high speeds, sedentary (less than 60 minutes of physical activity per week), no mobility limitations, not using any assistive walking tools like canes or walkers currently, no balance problems in history, not expecting pregnancy within next 12 months."

Answered by AI

Are there still opportunities to join this research trial?

"Affirmative. As indicated on clinicaltrials.gov, this research is presently enrolling participants with an initial post date of January 4th 2022 and most recent update on October 6th 2022. The endeavour seeks to recruit 40 patients from 3 distinct sites."

Answered by AI

What is the enrollment size of this research endeavor?

"Affirmative. The information found on clinicaltrials.gov asserts that this experiment is currently enrolling participants, with the first post being made on April 1st 2022 and a recent update occurring on October 6th of the same year. Forty patients need to be recruited from three distinct medical sites."

Answered by AI

What aims is this medical experiment attempting to achieve?

"This study is set to evaluate a particular exercise intervention program over the course of 12 weeks. The primary outcome being measured will be average duration of sessions, while secondary outcomes include changes in picture sequence performance, picture vocabulary performance and flanker task performance - all indicative or worse cognitive ability with lower numbers indicating poorer results."

Answered by AI
~1 spots leftby Apr 2025